Seattle genetics responds to daiichi sankyo's complaint for declaratory judgment

Seattle genetics responds to daiichi sankyo's complaint for declaratory judgment.seattle genetics-adc technology used in daiichi sankyo's metastatic breast cancer drug candidate "rightfully belongs to" co under 2008 deal between cos.

SGEN Ratings Summary

SGEN Quant Ranking